• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MICRO's Costa Rica Facility Achieves ISO 13485:2016 Certification

    FDA Clears SafeSource Direct's Nitrile Exam Gloves

    Baxter, Miromatrix Team Up for Bioengineered Liver

    BlackHägen Design Members Named as Contributing Inventors in Bayer Patent

    The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Deep (Brain) Thoughts with Medtronic's Neuromodulation President

    Grab and Go: Examining the Thrombectomy Device Market

    Fine Print: A Discourse on Additive Manufacturing

    MPO's 2022 Medtech Industry Year in Review

    Micro Molding for Medtech Is Miniature Magic
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Reflections on 2022 and What’s Ahead for Medtech: MPO Sounding Board

    3 Ways to Prepare for ISO 13485/Part 820 Harmonization

    A New Home for Theranos' Elizabeth Holmes?

    Health Cost Drivers for Large Employers

    Braving Change: Facing Fears in the Midst of Major Transitions
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Artificial Intelligence Can Combat Key Issues Impacting Healthcare

    Why Advanced Sensors Are Crucial Within Medical Pumps

    How Artificial Intelligence Could Help Prevent 80% of Chronic Diseases

    4 Ways to Use Injection Molding in Medical Device Manufacturing

    Telemedicine and Connectivity to Drive Material Innovation in the Near Future
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Fusion Biotec Inc.

    Providence Enterprise USA Inc.

    JBC Technologies

    Arthur G. Russell Co. Inc., The

    NDH Medical Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Medtronic Gains Health Canada Licence for Drug-Coated Balloon

    IN.PACT Admiral drug-coated balloon helps reopen blood vessels in legs narrowed by peripheral artery disease.

    Medtronic Gains Health Canada Licence for Drug-Coated Balloon
    IN.PACT Admiral Drug-Coated Balloon
    Related CONTENT
    • FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    • Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses
    • Medtronic Launches Advanced StealthStation for Neurosurgery
    • GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD
    • FDA Clears Medtronic's Insertable Cardiac Monitor with TruRhythm Detection
    Medtronic02.13.17
    Medtronic Canada, a subsidiary of Medtronic plc, announced it has obtained Health Canada licence for the IN.PACT Admiral Drug-Coated Balloon (DCB). IN.PACT Admiral DCB is a primary endovascular device used in patients with peripheral artery disease (PAD) in the upper leg—specifically, in the thigh (superficial femoral arteries) and behind the knee (popliteal arteries). Affecting an estimated 800,000 people in Canada, PAD is a debilitating disease that occurs when arteries become narrowed or blocked by plaque build-up, restricting blood flow.1
     
    The procedure involves inserting a compressed balloon into the artery, inflating the balloon to re-open the blockage, and then removing it. But unlike traditional alternatives like stents or plain balloons, the DCB leaves behind medication designed to help prevent the artery from narrowing (restenosis). 
     
    What distinguishes the IN.PACT Admiral DCB from other alternatives for PAD is the coating formulation, composed of a proven anti-proliferative drug (paclitaxel) and an excipient (urea). Once inflated, the coating comes into contact with water in the bloodstream, which hydrates the urea, facilitating the release of solid-phase paclitaxel to the vessel wall to help prevent restenosis.
     
    “What many people don’t realize is that PAD in the legs is often connected to health conditions in other parts of the body, especially in the heart,” said Michael Blackwell, senior director of Medtronic’s CardioVascular Group in Canada. “With drug-coated balloons, we now have a way to more effectively reduce plaque build-up caused by PAD, and we are excited that hospitals in Canada are now able to offer this new technology.” 

    PAD commonly affects arteries in the upper legs and can cause recurrent and painful muscle cramping in the thigh and/or upper calf. The pain can be described as dull, causing heaviness or tightness in the muscles, but often will stop when the person is at rest. Experiencing pain, even while at rest or while sleeping is often a sign of a more severe disease. If not properly treated, PAD can lead to life-threatening complications, and is associated with a four to five times higher risk for heart attack or stroke.2
     
    Supported by a robust body of evidence, IN.PACT Admiral DCB has been studied in more than 20 individual clinical trials demonstrating durable safety and clinical benefits. Recently, three-year data from the IN.PACT SFA clinical trial shared at the 2016 Vascular Interventional Advances (VIVA) Conference demonstrated the highest rate of primary patency and lowest rate of clinically driven target lesion revascularization in a pivotal study of interventional treatments for PAD.3

    “Patients experiencing incapacitating intermittent claudication or rest pain need a safe and durable treatment option,” said Dr. Andrew Benko, Centre Hospitalier Universitaire de Sherbrooke (CHUS). “In my practice, IN.PACT Admiral DCB will be the device of choice for such patients with femoropopliteal lesions giving the opportunity for outstanding clinical results with very low reintervention rates. This technology has been one of the most significant advancements I have seen in the endovascular management of PAD.” 
     
    References
    1 National Heart Lung And Blood Institute (Nhlbi). Facts About Peripheral Arterial Disease (P.A.D.) (n.d.): n. pag. Web.
    2 Aboyans, Victor, Ileana Desormais, Philippe Lacroix, Johanna Salazar, Michael H. Criqui, and Marc Laskar. "The General Prognosis of Patients With Peripheral Arterial Disease Differs According to the Disease Localization." JAMA. 55.9 (2010): 898-903.
    3 Krishnan, P., IN.PACT SFA Randomized Trial: Drug-Coated Balloons Show Superior 3-Year Outcomes Versus Standard Angioplasty. Vascular Interventional Advances (VIVA) 2016.
    Related Searches
    • clinical trial
    • nhlbi
    • institute
    • blood
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses
    Medtronic Launches Advanced StealthStation for Neurosurgery Medtronic Launches Advanced StealthStation for Neurosurgery
    GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD
    FDA Clears Medtronic FDA Clears Medtronic's Insertable Cardiac Monitor with TruRhythm Detection
    Balloon Technology Study Launched for Treatment of Below-The-Knee PAD Balloon Technology Study Launched for Treatment of Below-The-Knee PAD
    Positive Results in Medtronic CRT Reverse Trial Positive Results in Medtronic CRT Reverse Trial
    CE Mark for Medtronic’s Next Generation CRT Pacemakers CE Mark for Medtronic’s Next Generation CRT Pacemakers
    FDA OKs Expanded Indication for Medtronic’s Cryoablation Catheter FDA OKs Expanded Indication for Medtronic’s Cryoablation Catheter
    Medtronic’s CardioInsight Mapping Solution Cleared by FDA Medtronic’s CardioInsight Mapping Solution Cleared by FDA
     PQ Bypass Announces Positive Results From DETOUR I Study PQ Bypass Announces Positive Results From DETOUR I Study
    Medtronic & Fitbit Partner on New CGM Solution for Simplified Type 2 Diabetes Management Medtronic & Fitbit Partner on New CGM Solution for Simplified Type 2 Diabetes Management

    Related Breaking News

    • Cardiovascular
      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers

      Portfolio of heart failure devices offers effective pacing and access to the most advanced diagnostic imaging procedures.
      Medtronic plc 05.11.17

    • Cardiovascular
      Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses

      Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses

      The IN.PACT Admiral device demonstrated comparable clinically driven target lesion revascularization rates.
      Medtronic plc 05.04.17

    • Neurological | Surgical
      Medtronic Launches Advanced StealthStation for Neurosurgery

      Medtronic Launches Advanced StealthStation for Neurosurgery

      New platform to offer flexibility, ease of use, improved registration, and advanced visualization for custom workflows.
      Medtronic plc 04.24.17


    • Cardiovascular
      GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD

      GORE TIGRIS Vascular Stent Gains Health Canada Approval for Treatment of PAD

      Device combines proven technology with modern adaptations to provide support in challenging anatomies.
      Business Wire 03.20.17

    • Cardiovascular | Digital Health | Electronics | Patient Monitoring | Software & IT
      FDA Clears Medtronic

      FDA Clears Medtronic's Insertable Cardiac Monitor with TruRhythm Detection

      Device delivers improved accuracy and streamlined data for clinicians.
      Medtronic 03.13.17

    Loading, Please Wait..

    Trending
    • The Future Of Biomedical Engineering Advancements
    • Cirtec Medical Corporation Acquires Precision Components Business From QMD
    • Medtronic's Recall Of Mahurkar Catheters Is Class I
    • Coloplast Launches New Catheter In The U.S.
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • FDA Clears H2o Therapeutics' Parkinson's Disease Monitoring App
    • MICRO's Costa Rica Facility Achieves ISO 13485:2016 Certification
    • FDA Clears SafeSource Direct's Nitrile Exam Gloves
    • Baxter, Miromatrix Team Up for Bioengineered Liver
    • BlackHägen Design Members Named as Contributing Inventors in Bayer Patent
    View Breaking News >
    CURRENT ISSUE

    November 2022

    • MPO's 2022 Year in Review
    • Fine Print: A Discourse on Additive Manufacturing
    • Grab and Go: Examining the Thrombectomy Device Market
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    BAPP Paper Reviews Common Adulteration Practices Which Go Undetected
    CRN Announces Promotions and Welcomes New Staff Member
    Quercetin Ingredient Linked to Improved COVID-19 Recovery: Study
    Coatings World

    Latest Breaking News From Coatings World

    ROSS Offers Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    PPG Achieves ISO 14001 Certification of Environmental Management System
    AmCoat’s Rhino Shield and Floor Shield Break Records in 2022
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Baxter, Miromatrix Team Up for Bioengineered Liver
    BlackHägen Design Members Named as Contributing Inventors in Bayer Patent
    The Producto Group Appoints Mark C. Rauenzahn as Chief Executive Officer
    Contract Pharma

    Latest Breaking News From Contract Pharma

    HPNE Launches New Approach to Single-Use Assembly Production
    Andelyn Biosciences, Odylia Therapeutics Partner to Manufacture Gene Therapy for Vision Loss
    Lonza Breaks Ground on Commercial Drug Product Facility in Stein
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    L’Oréal Group Recognized by Bloomberg Gender-Equality Index 2023
    Unilever Ventures Invests in Aussie Scalp Care Brand Straand
    La Roche-Posay Named the Fastest Growing Skincare Brand of 2022 by NielsenIQ
    Happi

    Latest Breaking News From Happi

    Perfect Corp Partners with Beekman 1802 for New My Skin Biome Tool
    OPI’s Nature Strong Introduces Botanical Base Coat and New Colors
    Inclusive Hair Brand Hairitage Launches New Anti-Dandruff Collection at Walmart
    Ink World

    Latest Breaking News From Ink World

    C3Nano Offers New SuperGrid Flexible Low-Temperature Ink
    ROSS Develops Heavy-Duty Three Roll Mills for High Viscosity Dispersions
    Alexander's Adds Two New HP Indigo 100K Digital Presses to Fleet
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Baker Labels invests in Digicon 3000 for flexible packaging division
    PIM promotes Kristin Pilling-Davis to executive director
    Stratus Packaging embraces automation with Bobst
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    WPT Nonwovens to Add Thermobonding Line in Kentucky
    Superior Felt & Filtration Adds Domestic Injection Molding to its Medical Filtration Capabilities
    Ahlstrom Launches New Generation FluoroFree Technology
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Solid Growth Ahead for Orthopedic Power Tools Market
    Mobi-C Cervical Disc Replacement Procedures Top 200,000
    OPUM, Corflex Global Partner on Knee Assessment Technology
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Angèle Reinders Named New Director of Solliance
    C3Nano Launches New SuperGrid Flexible Low-Temperature Ink
    PPG Earns ISO 14001 Certification of Environmental Management

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login